Literature DB >> 28194474

A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?

A Morton1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28194474     DOI： 10.1007/s00198-017-3922-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  5 in total

1.  Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.

Authors:  Andrea Giusti; Antonella Barone; Giulio Pioli; Giuseppe Girasole; Vincenzo Siccardi; Ernesto Palummeri; Gerolamo Bianchi
Journal:  Nephrol Dial Transplant       Date:  2008-12-15       Impact factor: 5.992

2.  Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.

Authors:  Miguel Angel Arrabal-Polo; Salvador Arias-Santiago; Tomas de Haro-Muñoz; Adriana Lopez-Ruiz; Jacinto Orgaz-Molina; Samuel Gonzalez-Torres; Armando Zuluaga-Gomez; Miguel Arrabal-Martin
Journal:  Urology       Date:  2013-01-30       Impact factor: 2.649

3.  Continuous and long-term treatment is more important than dosage for the protective effect of thiazide use on bone metabolism and fracture risk.

Authors:  C Kruse; P Eiken; P Vestergaard
Journal:  J Intern Med       Date:  2015-07-30       Impact factor: 8.989

Review 4.  Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.

Authors:  A D Dede; G Trovas; E Chronopoulos; I K Triantafyllopoulos; I Dontas; N Papaioannou; S Tournis
Journal:  Osteoporos Int       Date:  2016-08-08       Impact factor: 4.507

5.  Deferasirox at therapeutic doses is associated with dose-dependent hypercalciuria.

Authors:  Phillip Wong; Kevan Polkinghorne; Peter G Kerr; James C G Doery; Matthew T Gillespie; I Larmour; Peter J Fuller; Donald K Bowden; Frances Milat
Journal:  Bone       Date:  2016-01-21       Impact factor: 4.398
  5 in total
  1 in total

1.  Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?

Authors:  A D Dede; G Trovas; E Chronopoulos; I K Triantafyllopoulos; I Dontas; N Papaioannou; S Tournis
Journal:  Osteoporos Int       Date:  2017-02-13       Impact factor: 4.507
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.